Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Johnson EM et al. | Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. | 1998 | Antimicrob. Agents Chemother. | pmid:9624486 |
Alonso MA et al. | Compounds affecting membranes that inhibit protein synthesis in yeast. | 1979 | Antimicrob. Agents Chemother. | pmid:394675 |
te Welscher YM et al. | Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. | 2010 | Antimicrob. Agents Chemother. | pmid:20385867 |
Kasbekar DP et al. | Self-induced nystatin resistance in Dictyostelium discoideum. | 1985 | Antimicrob. Agents Chemother. | pmid:4026273 |
Boyce ST et al. | Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes. | 1995 | Antimicrob. Agents Chemother. | pmid:7574524 |
Venables P and Russell AD | Nystatin-induced changes in Saccharomyces cerevisiae. | 1975 | Antimicrob. Agents Chemother. | pmid:1094947 |
Randhawa P et al. | BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport. | 2007 | Antimicrob. Agents Chemother. | pmid:17893158 |
Serfling A et al. | Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. | 2007 | Antimicrob. Agents Chemother. | pmid:17620378 |
Offner F et al. | Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B. | 2004 | Antimicrob. Agents Chemother. | pmid:15561860 |
Bruheim P et al. | Chemical diversity of polyene macrolides produced by Streptomyces noursei ATCC 11455 and recombinant strain ERD44 with genetically altered polyketide synthase NysC. | 2004 | Antimicrob. Agents Chemother. | pmid:15504830 |